|
APPL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.9984599999967E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.019100E-03 |
| Normal-vs-Stage2 |
2.724600E-01 |
| Normal-vs-Stage3 |
5.091400E-01 |
| Normal-vs-Stage4 |
5.352400E-01 |
| Stage1-vs-Stage2 |
7.131800E-01 |
| Stage1-vs-Stage3 |
1.866580E-01 |
| Stage1-vs-Stage4 |
1.649250E-01 |
| Stage2-vs-Stage3 |
5.777200E-01 |
| Stage2-vs-Stage4 |
2.536200E-01 |
| Stage3-vs-Stage4 |
3.772200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.572700E-04 |
| Normal-vs-AfricanAmerican |
1.742910E-03 |
| Normal-vs-Asian |
4.296100E-03 |
| Caucasian-vs-AfricanAmerican |
2.292800E-01 |
| Caucasian-vs-Asian |
8.277600E-02 |
| AfricanAmerican-vs-Asian |
4.715700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14539999999763E-05 |
| Normal-vs-Female |
4.668300E-02 |
| Male-vs-Female |
4.011000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.614000E-01 |
| Normal-vs-Extreme_Weight |
5.204400E-01 |
| Normal-vs-Obese |
1.060340E-03 |
| Normal-vs-Extreme_Obese |
3.771800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.052000E-01 |
| Normal_Weight-vs-Obese |
1.555960E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.483800E-01 |
| Extreme_Weight-vs-Obese |
1.064250E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.919400E-01 |
| Obese-vs-Extreme_Obese |
6.099200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.025600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.15929999999909E-05 |
| Normal-vs-Age(61-80Yrs) |
1.340280E-02 |
| Normal-vs-Age(81-100Yrs) |
7.359600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.656200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.694200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.855410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.391180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.220200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.393600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62169999984307E-07 |
| Normal-VS-Type2 PRCC |
4.188400E-01 |
| Normal-VS-KIRP CIMP |
2.157600E-01 |
| Normal-VS-Unclassified PRCC |
9.681600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.282000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.815510E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.563400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.668800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.118000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.698700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.518600E-01 |
| Normal-vs-N1 |
1.925440E-01 |
| Normal-vs-N2 |
3.960000E-02 |
| N0-vs-N1 |
4.462600E-01 |
| N0-vs-N2 |
2.933000E-01 |
| N1-vs-N2 |
2.549800E-01 |
|
|
